| scholarly article | Q13442814 |
| P50 | author | Janet J. Maguire | Q51749680 |
| P2093 | author name string | A P Davenport | |
| R E Kuc | |||
| P2860 | cites work | Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 | Q22010575 |
| Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors | Q24322675 | ||
| Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord | Q24656200 | ||
| Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction | Q28137875 | ||
| Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14 | Q28139196 | ||
| ETA receptor‐mediated constrictor responses to endothelin peptides in human blood vessels in vitro | Q28367973 | ||
| LIGAND: A versatile computerized approach for characterization of ligand-binding systems | Q29547346 | ||
| A novel potent vasoconstrictor peptide produced by vascular endothelial cells | Q29620540 | ||
| Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). | Q30807054 | ||
| Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology | Q33720595 | ||
| Urotensin II: fish neuropeptide catches orphan receptor | Q33846563 | ||
| Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type | Q34793212 | ||
| Complex effects of Gillichthys urotensin II on rat aortic strips | Q35754681 | ||
| Neuropeptide-induced contraction and relaxation of the mouse anococcygeus muscle | Q36248341 | ||
| Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes | Q36404166 | ||
| Neurohormones from fish tails: the caudal neurosecretory system. I. "Urophysiology" and the caudal neurosecretory system of fishes | Q39396237 | ||
| Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. | Q43264408 | ||
| Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. | Q47928974 | ||
| A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia | Q48074434 | ||
| Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. | Q48418381 | ||
| Cardiovascular effects of urotensin II in anesthetized and pithed rats. | Q51800313 | ||
| Differential distribution of endothelin peptides and receptors in human adrenal gland | Q56988136 | ||
| Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta | Q56988144 | ||
| Functional receptors for fish neuropeptide urotensin II in major rat arteries | Q68449521 | ||
| Contraction of major artery segments of rat by fish neuropeptide urotensin II | Q69741441 | ||
| Differential distribution of angiotensin AT2 receptors in the normal and failing human heart | Q74064536 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 441-6 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1 | |
| P478 | volume | 131 |
| Q57771763 | 1,3,4-Thiadiazol-2-amine Derivatives as Urotensin-II Receptor (UT) Antagonists |
| Q47431351 | A Comparison of Cerebrospinal Fluid and Plasma Urotensin II Concentrations in Normotensive and Hypertensive Patients Undergoing Urological Surgery During Spinal Anesthesia: A Pilot Study |
| Q36492706 | A closer look at the role of urotensin II in the metabolic syndrome |
| Q40703439 | A new ligand for the urotensin II receptor |
| Q42139903 | A new therapeutic approach to erectile dysfunction: urotensin-II receptor high affinity agonist ligands |
| Q37737587 | A rat brain atlas of urotensin-II receptor expression and a review of central urotensin-II effects |
| Q37660867 | Acute Effect of Central Administration of Urotensin II on Baroreflex and Blood Pressure in Conscious Normotensive Rabbits |
| Q89884928 | Association between Plasma Urotensin II and Risk of Hypertension: Findings from a Prospective Study |
| Q42667921 | Behavioral effects of urotensin-II centrally administered in mice |
| Q28260943 | Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes |
| Q35043105 | Cardiostimulant effects of urotensin-II in human heart in vitro |
| Q76383741 | Cardiovascular actions of human urotensin II--considerations for hypertension |
| Q44036542 | Congestive heart failure and expression of myocardial urotensin II. |
| Q42215972 | Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice |
| Q43264253 | Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats |
| Q58855829 | Design, Synthesis, Conformational Analysis, and Biological Studies of Urotensin-II Lactam Analogues |
| Q34677468 | Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. |
| Q48626800 | Does cigarette smoking increase plasma urotensin II concentrations? |
| Q73307200 | Effect of human urotensin-II infusion on hemodynamics and cardiac function |
| Q37427914 | Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus |
| Q36800470 | Effects of Urotensin II Receptor Antagonist, GSK1440115, in Asthma |
| Q28177421 | Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure |
| Q35033297 | Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system |
| Q64078200 | Evaluation of Endothelial Dysfunction in Bipolar Affective Disorders: Serum Endocan and Urotensin-II Levels |
| Q93551696 | G Protein-Coupled Receptors |
| Q43229377 | Human urotensin II in internal mammary and radial arteries of patients undergoing coronary surgery. |
| Q40122555 | Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease. |
| Q43927991 | Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists |
| Q34204725 | Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease |
| Q35047377 | Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines |
| Q35098581 | In vitro and in vivo pharmacological characterization of the novel UT receptor ligand [Pen5,DTrp7,Dab8]urotensin II(4-11) (UFP-803) |
| Q48188894 | In vitro siRNA-mediated knockdown of the UT receptor: implications of density on the efficacy of a range of UT ligands |
| Q57771749 | Indole-2-carboxamide Derivatives as Potent Urotensin-II Receptor (UT) Antagonists |
| Q34087759 | Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptor |
| Q53266606 | Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis. |
| Q44035248 | Involvement of the nitric oxide/L-arginine and sympathetic nervous systems on the vasodepressor action of human urotensin II in anesthetized rats |
| Q88874237 | Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly? |
| Q24672927 | Is urotensin-II the new endothelin? |
| Q48675996 | Localization of the urotensin II receptor in the rat central nervous system |
| Q40735770 | Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey |
| Q42284302 | No effect on central or peripheral blood pressure of systemic urotensin II infusion in humans. |
| Q40430686 | Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375. |
| Q39967100 | Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues |
| Q39236752 | Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension. |
| Q45922685 | Pharmacokinetics and pharmacodynamics of the urotensin-II receptor antagonist palosuran in healthy male subjects. |
| Q43263666 | Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonist |
| Q28216724 | Plasma levels and cardiovascular gene expression of urotensin-II in human heart failure |
| Q36809037 | Plasma urotensin-2 level and Thr21Met but not Ser89Asn polymorphisms of the urotensin-2 gene are associated with migraines |
| Q35128456 | Potential Clinical Implications of the Urotensin II Receptor Antagonists |
| Q34001118 | Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis |
| Q34154714 | Retracted: Endogenous Urotensin II Selectively Modulates Erectile Function through eNOS |
| Q36902874 | Role of urotensin II and its receptor in health and disease |
| Q37737495 | Role of urotensin II in health and disease |
| Q74531870 | Role of urotensin II in patients on dialysis |
| Q58855647 | Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position 9 |
| Q30486707 | The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors |
| Q33599835 | The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features |
| Q42283626 | The effects of urotensin II and urantide on forearm blood flow and systemic haemodynamics in humans. |
| Q28241656 | The expression of urotensin II receptor (U2R) is up-regulated by interferon-gamma |
| Q49526717 | The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study |
| Q24675590 | The role of urotensin II in cardiovascular and renal physiology and diseases |
| Q28211211 | The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat |
| Q36760529 | Therapeutic potential of blockade of the urotensin II system in systemic hypertension |
| Q37082781 | Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? |
| Q41767436 | Update on the urotensinergic system: new trends in receptor localization, activation, and drug design |
| Q41819007 | Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta |
| Q28576132 | Urotensin II and renal function in the rat |
| Q44654245 | Urotensin II causes fatal circulatory collapse in anesthesized monkeys in vivo: a “vasoconstrictor” with a unique hemodynamic profile |
| Q41834073 | Urotensin II evokes potent vasoconstriction in humans in vivo |
| Q37344439 | Urotensin II in cardiovascular regulation |
| Q81793693 | Urotensin II in patients with chronic heart failure |
| Q48627768 | Urotensin II inhibits carotid sinus baroreflex in anesthetized male rats |
| Q44463826 | Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney |
| Q48877778 | Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat. |
| Q74531840 | Urotensin II: a new mediator in cardiopulmonary regulation? |
| Q28250440 | Urotensin II: ancient hormone with new functions in vertebrate body fluid regulation |
| Q85276064 | Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension |
| Q93498779 | Urotensin-II |
| Q38093584 | Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures |
| Q35779239 | Urotensin-II and the cardiovascular system--the importance of developing modulators |
| Q83315856 | Urotensin-II in systemic sclerosis: a new peptide in pathogenesis |
| Q36357772 | Urotensin-II induces ear flushing in rats |
| Q42418210 | Urotensin-II: More Than a Mediator for Kidney |
| Q76383739 | Urotensin-II: a novel systemic hypertensive factor in the cat |
| Q35536658 | Vasoconstrictive effects of endothelin-1, endothelin-3, and urotensin II in isolated perfused human lungs and isolated human pulmonary arteries |
| Q28360176 | [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man |
Search more.